Egis is one of the winners of the Swedish Chamber of Commerce in Hungary’s Gran Prize for interdisciplinary innovations

Outstanding industrial innovations for sustainability were awarded on the 23th of May for the sixth time. This year, Egis has received the prize for a wastewater dehalogenation method. details >

Egis keeps growing in OTC markets via acquisition

Egis Pharmaceuticals PLC acquired Sinuforte, a nasal spray from Hartington Business S.L. Egis seeks to ensure its growing presence in major export markets, Russia and the CIS countries through organic growth and targeted acquisitions. details >

Egis intensifies its acquisition strategy in 2017

Egis Pharmaceuticals PLC has acquired Sorbifer’s product rights from AstraZeneca. The transaction reinforces Egis’ position on its key markets. details >

Egis is one of the most attractive workplaces in the pharma industry

Our company was awarded based on the evaluation of employees and job seekers. details >

Dr. Klára András will be HR Director of Egis Pharmaceuticals PLC

from April 1, 2017 details >

Egis strengthens presence in Russia by OTC acquisition

Egis acquired Russian D-Panthenol and women’s health product portfolio from Jadran-Galenski Laboratorij’s (JGL). details >